| CEO: | Phil L'Huillier |
| CFO: | Sath Nirmalananthan |
| Chief Scientific Officer: | Lindy Durrant |
| Deputy Chairman: | Susan Clement Davies |
| Non-Executive Chairman: | Jean-Michel Cosséry |
| Non-Executive Dir: | Martin Diggle , Ursula Ney, Florian Reinaud |
| Address: | Bellhouse Building, Sanders Road, Oxford Science Park, Oxford, United Kingdom , OX4 4GD |
| Website: | http://www.scancell.co.uk/ |
| Sector: | Pharma and Biotech(LSE) |
| Index: | FTSE AIM All-Share |
| ISIN: | GB00B63D3314 |
| Currency | UK Pounds |
| Share Price | 11.70p |
| Change Today | -0.15p |
| % Change | -1.27 % |
| 52 Week High | 12.25 |
| 52 Week Low | 7.50 |
| Volume | 27,745 |
| Shares Issued | 1,037.78m |
| Market Cap | £121.42m |
| Beta | 0.82 |
| Value | ![]() |
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth | ![]() |
|---|
| No dividends found |
| Time | Volume / Share Price |
| 10:06 | 3,747 @ 12.17p |
| 10:05 | 550 @ 12.17p |
| 09:58 | 4,009 @ 12.17p |
| 09:41 | 1 @ 12.18p |
| 09:32 | 411 @ 12.18p |
| CFO | Sath Nirmalananthan |
| CEO | Phil L'Huillier |
You are here: research